Xeris Pharmaceuticals Enters Collaboration Agreement With Merck - NewsBreak Home > Business > Article
3 years ago By Bryan — Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endoc
#xerispharmaceuticalsenterscollaboration #merck